NCT06190366

Brief Summary

Evaluation of a bloodletting acupuncture at the fossa poplitea in comparison to bloodletting acupuncture at the regio glutaea and a waiting list control group in patients with subacute and chronic non-specific pain low back pain.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
108

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 19, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

December 19, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 5, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

January 5, 2024

Status Verified

January 1, 2024

Enrollment Period

12 months

First QC Date

December 19, 2023

Last Update Submit

January 3, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in average pain intensity in previous week

    Intensity of pain in previous week as measured on a 100 mm visual analog scale (0-100).

    Baseline, 3 weeks

Secondary Outcomes (9)

  • Change from baseline in average pain intensity in previous week

    Baseline, 6 weeks

  • Change from baseline in average pain intensity of the last 24 hours

    Baseline, 3 weeks, 6 weeks

  • Change from baseline for back pain specific disability

    Baseline, 3 weeks, 6 weeks

  • Change from baseline in pain bothersomeness in previous week

    Baseline, 3 weeks, 6 weeks

  • Change from baseline for days with pain medication use

    Baseline, 3 weeks, 6 weeks

  • +4 more secondary outcomes

Other Outcomes (3)

  • Number of participants with adverse events as a measure of safety and treatment adherence

    3 weeks, 6 weeks

  • Treatment adherence

    3 weeks

  • Treatment expectation: effectiveness of bloodletting acupuncture in reducing low back pain

    Baseline

Study Arms (3)

Bloodletting acupuncture at the fossa poplitea

EXPERIMENTAL
Procedure: Bloodletting acupuncture at the fossa poplitea

Bloodletting acupuncture at the regio glutaea

EXPERIMENTAL
Procedure: Bloodletting acupuncture at the regio glutaea

Waiting list control group

NO INTERVENTION

Interventions

This group is treated with bloodletting acupuncture at the fossa poplitea. The treatment takes place twice a week from week 1 to week 3. This means that 6 treatments of approx. 20 minutes each should be carried out within the 3 weeks.

Bloodletting acupuncture at the fossa poplitea

This group is treated with bloodletting acupuncture at the regio glutaea. The treatment takes place twice a week from week 1 to week 3. This means that 6 treatments of approx. 20 minutes each should be carried out within the 3 weeks.

Bloodletting acupuncture at the regio glutaea

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Average pain intensity with at least 50 mm on the VAS from 0 to 100 mm

You may not qualify if:

  • Serious illnesses
  • Poor general condition
  • Coagulation disorder, therapy with anticoagulants
  • Thrombophlebitis, skin inflammation in the area of the lower extremities
  • Alcohol, drug or medication addiction
  • Pregnancy
  • Lack of willingness to cooperate, linguistically or mentally unable to understand the contents of the study
  • Participation in another clinical trial during the study period
  • Starting a new therapy for the treatment of low back pain in the last 2 weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Charité Hochschulambulanz für Naturheilkunde, Immanuel Krankenhaus Berlin

Berlin, 14163, Germany

RECRUITING

MeSH Terms

Conditions

Low Back Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 19, 2023

First Posted

January 5, 2024

Study Start

December 19, 2023

Primary Completion

December 1, 2024

Study Completion

December 1, 2025

Last Updated

January 5, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations